• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

University at Buffalo

Headquarters: Buffalo, NY, United States
Website: http://www.buffalo.edu
Year Founded: 1846
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Apr 9, 2024
Deals

Deals report: Merck buying Buffalo academic spinout to enhance ADCs

Plus more antibody-drug conjugate deals: Ipsen-Sutro, Merck KGaA-Caris
Read More
BioCentury | Feb 10, 2022
Discovery & Translation

Translational trendspotting: a Distillery dive into neurology

Highlights include a new approach to the amyloid hypothesis, white space strategies for stroke and gene therapies
Read More
BioCentury | Dec 3, 2021
Discovery & Translation

Mapping the plasma proteome to identify drug targets; plus GSK-Vir, Codiak and more

BioCentury’s roundup of translational news
Read More
BioCentury | Oct 27, 2021
Distillery Therapeutics

A lipidated peptide inhibitor of nociceptor endocytosis for inflammatory pain

Read More
BioCentury | Jan 30, 2021
Distillery Therapeutics

Targeting histone trimethylation to treat Alzheimer’s

DISEASE CATEGORY: Neurology
INDICATION: Alzheimer’s disease Inhibiting WDR5, a core subunit of the MLL family of histone methyltransferases, or its downstream target SGK1 could treat
Read More
BioCentury | Apr 30, 2020
Distillery Therapeutics

Heparan sulfate for prevention of acetaminophen-induced acute liver failure

Read More
BioCentury | Aug 8, 2018
Distillery Therapeutics

Neurology

Read More
BioCentury | Feb 9, 2018
Company News

China-U.S. research collaboration launched

Read More
BioCentury | Feb 5, 2018
Company News

China-U.S. translational research collaboration launched

Read More
BioCentury | Jan 3, 2018
Product R&D

Expanding small molecule horizons

How 5AM newco Expansion Therapeutics is hitting RNA targets with small molecules
Read More
Items per page:
1 - 10 of 19